Delivery Order SPE2DR25D3003-SPE2DR26F5QH2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Jadenu 360 mg tablets (30-count units) with a ceiling value of $20,184.03. This firm fixed-price delivery order, which is scheduled for completion by October 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The award was made through...
- The Defense Logistics Agency awarded a delivery order valued at $84,982.81 to AmerisourceBergen Drug Corp for the supply of Jadenu 360 mg tablets (30-count units) on October 15, 2025, with an ultimate completion date of October 16, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $12,031.54 delivery order to AmerisourceBergen Drug Corp for Jadenu 360 mg tablets (30-count units) on October 24, 2025, with an ultimate completion date of October 27, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $25,105.23 to AmerisourceBergen Drug Corp for JADENU 360 mg tablets (30-count packages) on November 20, 2025, with completion scheduled for November 21, 2025. This firm fixed-price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp received a $37,524.35 delivery order from the Defense Logistics Agency (DLA) on July 17, 2025, for the supply of Jadenu 360 mg tablets (30-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by July 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jadenu is an iron chelation therapy medication used to treat chronic iron overload, a condition common...
- The Defense Logistics Agency awarded a $17,333.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for JADENU 360 mg tablets (30-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for JADENU 360 mg tablets (30-count package) valued at $17,387.95 under a firm fixed price contract type. The award, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, represents a competitive procurement with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $40,176.29 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of JADENU 360 mg tablets (30-count packages). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $21,735.08 to AmerisourceBergen Drug Corp for JADENU 360 mg tablets (30-count) on October 30, 2025, with completion scheduled for October 31, 2025. This firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate headquarters location in Conshohocken, Pennsylvania. As a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $25,015.31 to AmerisourceBergen Drug Corp for the supply of JADENU 360 mg tablets (30-count) under a firm fixed-price contract type. The award was made on September 10, 2025, with an ultimate completion date of September 11, 2025, and is not designated as a set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- SPE2DR25D3003Indefinite Delivery Contract
- SPE2DR25D3003-SPE2DR26F5QH2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $46,261.42 to AmerisourceBergen Drug Corp for 30-tablet bottles of Jadenu 360 mg on December 10, 2025, with a completion date of December 11, 2025. The award was competitively procured without set-aside designation and is structured as a firm fixed-price delivery order. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and supplies a comprehensive range of pharmaceutical products to support military and veteran healthcare systems. Jadenu (deferasirox) is an oral iron chelation therapy used in the treatment of chronic iron overload, reflecting the company's role in providing specialized medications across multiple therapeutic domains. The underlying IDC vehicle enables AmerisourceBergen to supply brand-name and generic drugs, vaccines, medical devices, and specialized healthcare commodities to customers including the Defense Health Agency and U.S. Coast Guard on a global basis, positioning the company as a key provider within the DLA's pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46.3k | 12/9/25 |